| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 NFATC3 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B MLXIPL ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF66 CCAR1 ZNF525 ZNF454 ZNF726 ZNF682 | 1.27e-06 | 1244 | 204 | 32 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 NFATC3 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B MLXIPL ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF66 CCAR1 ZNF525 ZNF454 ZNF726 ZNF682 | 2.01e-06 | 1271 | 204 | 32 | GO:0000987 |
| GeneOntologyMolecularFunction | guanylate cyclase activity | 2.12e-06 | 10 | 204 | 4 | GO:0004383 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 NFATC3 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B MLXIPL ZSCAN5B ZNF732 ZNF253 ZNF92 BARHL2 ZNF667 ZNF66 CCAR1 ZNF525 ZNF454 ZNF726 ZNF682 | 1.32e-05 | 1459 | 204 | 33 | GO:0000977 |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.89e-05 | 18 | 204 | 4 | GO:0004016 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 NFATC3 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B MLXIPL ZSCAN5B ZNF732 ZNF253 ZNF92 BARHL2 ZNF66 ZNF525 ZNF454 ZNF726 ZNF682 | 4.39e-05 | 1412 | 204 | 31 | GO:0000981 |
| GeneOntologyMolecularFunction | cyclase activity | 9.58e-05 | 24 | 204 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 1.13e-04 | 25 | 204 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 3.10e-04 | 3 | 204 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | actin binding | MYO9B MYO10 SPTBN1 FMNL2 SPATA31C1 ADD3 DST DIAPH2 PLEKHH2 PLS3 KLHL4 COBLL1 MACF1 SSH2 | 4.29e-04 | 479 | 204 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity | 1.02e-03 | 5 | 204 | 2 | GO:0003831 | |
| GeneOntologyMolecularFunction | N-acetyllactosamine synthase activity | 1.02e-03 | 5 | 204 | 2 | GO:0003945 | |
| GeneOntologyBiologicalProcess | cGMP biosynthetic process | 3.92e-06 | 12 | 199 | 4 | GO:0006182 | |
| GeneOntologyBiologicalProcess | cGMP metabolic process | 2.91e-05 | 19 | 199 | 4 | GO:0046068 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-methionine acetylation | 3.01e-05 | 7 | 199 | 3 | GO:0017196 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 6.45e-05 | 23 | 199 | 4 | GO:0009190 | |
| GeneOntologyCellularComponent | cell cortex | CTTNBP2 MYO9B MYO10 SPTBN1 ADD3 DST EXOC3L1 PLEKHH2 FRMPD1 GUCY1B1 PDE4DIP MACF1 DCTN4 | 7.31e-05 | 371 | 203 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | N-terminal protein acetyltransferase complex | 1.03e-04 | 10 | 203 | 3 | GO:0031414 | |
| Domain | KRAB | ZNF273 ZNF267 ZNF195 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZNF732 ZNF253 ZNF92 ZNF667 ZNF454 ZNF726 ZNF682 | 1.70e-14 | 358 | 202 | 26 | PF01352 |
| Domain | KRAB | ZNF273 ZNF267 ZNF195 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZNF732 ZNF253 ZNF92 ZNF667 ZNF454 ZNF726 ZNF682 | 3.46e-14 | 369 | 202 | 26 | SM00349 |
| Domain | KRAB | ZNF273 ZNF267 ZNF195 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZNF732 ZNF253 ZNF92 ZNF667 ZNF454 ZNF726 ZNF682 | 3.69e-14 | 370 | 202 | 26 | IPR001909 |
| Domain | KRAB | ZNF273 ZNF267 ZNF195 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B ZNF732 ZNF253 ZNF92 ZNF667 ZNF454 ZNF726 ZNF682 | 1.37e-13 | 358 | 202 | 25 | PS50805 |
| Domain | zf-C2H2_6 | ZNF273 ZNF267 ZNF195 ZNF836 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF726 ZNF682 | 2.24e-10 | 314 | 202 | 20 | PF13912 |
| Domain | zf-C2H2 | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF525 ZNF454 ZNF726 ZNF682 | 4.20e-10 | 693 | 202 | 29 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF525 ZNF454 ZNF726 ZNF682 | 5.36e-09 | 775 | 202 | 29 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF525 ZNF454 ZNF726 ZNF682 | 5.68e-09 | 777 | 202 | 29 | PS00028 |
| Domain | Znf_C2H2 | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF525 ZNF454 ZNF726 ZNF682 | 1.25e-08 | 805 | 202 | 29 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF525 ZNF454 ZNF726 ZNF682 | 1.35e-08 | 808 | 202 | 29 | SM00355 |
| Domain | - | ZNF273 ZNF267 ZNF195 BCL6 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF454 ZNF726 ZNF682 | 2.26e-08 | 679 | 202 | 26 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF273 ZNF267 ZNF195 BCL6 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF454 ZNF726 ZNF682 | 3.51e-08 | 694 | 202 | 26 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF273 ZNF267 ZNF195 BCL6 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF454 ZNF726 ZNF682 | 5.07e-07 | 796 | 202 | 26 | IPR015880 |
| Domain | TPR_1 | 5.62e-07 | 90 | 202 | 9 | IPR001440 | |
| Domain | TPR_1 | 5.62e-07 | 90 | 202 | 9 | PF00515 | |
| Domain | TPR | 1.41e-06 | 129 | 202 | 10 | SM00028 | |
| Domain | TPR-contain_dom | 5.51e-06 | 150 | 202 | 10 | IPR013026 | |
| Domain | TPR-like_helical_dom | TTC21A TMTC2 PRPF6 TTC3 TTC6 PSMD6 CFAP54 TONSL NAA16 NAA15 TTC28 KLC4 | 9.19e-06 | 233 | 202 | 12 | IPR011990 |
| Domain | TPR_REGION | 1.28e-05 | 165 | 202 | 10 | PS50293 | |
| Domain | TPR | 1.28e-05 | 165 | 202 | 10 | PS50005 | |
| Domain | TPR_repeat | 1.45e-05 | 133 | 202 | 9 | IPR019734 | |
| Domain | TPR_8 | 2.23e-05 | 53 | 202 | 6 | PF13181 | |
| Domain | HNOB_dom_associated | 2.43e-05 | 6 | 202 | 3 | IPR011645 | |
| Domain | HNOBA | 2.43e-05 | 6 | 202 | 3 | PF07701 | |
| Domain | A/G_cyclase_CS | 2.83e-05 | 17 | 202 | 4 | IPR018297 | |
| Domain | - | 3.61e-05 | 18 | 202 | 4 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 3.61e-05 | 18 | 202 | 4 | IPR029787 | |
| Domain | Guanylate_cyc | 4.53e-05 | 19 | 202 | 4 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.53e-05 | 19 | 202 | 4 | PS50125 | |
| Domain | A/G_cyclase | 4.53e-05 | 19 | 202 | 4 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.53e-05 | 19 | 202 | 4 | PS00452 | |
| Domain | CYCc | 4.53e-05 | 19 | 202 | 4 | SM00044 | |
| Domain | - | 8.84e-05 | 207 | 202 | 10 | 1.25.40.10 | |
| Domain | zf-C2H2_11 | 9.98e-05 | 9 | 202 | 3 | PF16622 | |
| Domain | ACTININ_2 | 1.00e-04 | 23 | 202 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.00e-04 | 23 | 202 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.00e-04 | 23 | 202 | 4 | IPR001589 | |
| Domain | NatA_aux_su | 1.16e-04 | 2 | 202 | 2 | IPR021183 | |
| Domain | NARP1 | 1.16e-04 | 2 | 202 | 2 | PF12569 | |
| Domain | TPR_2 | 2.01e-04 | 50 | 202 | 5 | PF07719 | |
| Domain | TPR_2 | 2.01e-04 | 50 | 202 | 5 | IPR013105 | |
| Domain | Spectrin_repeat | 2.55e-04 | 29 | 202 | 4 | IPR002017 | |
| Domain | VDCC_T_a1 | 3.47e-04 | 3 | 202 | 2 | IPR005445 | |
| Domain | SPEC | 3.77e-04 | 32 | 202 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.77e-04 | 32 | 202 | 4 | IPR018159 | |
| Domain | Anaphylatoxin_comp_syst | 1.14e-03 | 5 | 202 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.14e-03 | 5 | 202 | 2 | IPR001840 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 3.90.1290.10 | |
| Domain | Clathrin_mu_CS | 1.70e-03 | 6 | 202 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 1.70e-03 | 6 | 202 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 1.70e-03 | 6 | 202 | 2 | PS00991 | |
| Domain | GAR | 1.70e-03 | 6 | 202 | 2 | PS51460 | |
| Domain | GAS2 | 1.70e-03 | 6 | 202 | 2 | PF02187 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 3.30.920.20 | |
| Domain | GABAAa_rcpt | 1.70e-03 | 6 | 202 | 2 | IPR001390 | |
| Domain | GAS_dom | 1.70e-03 | 6 | 202 | 2 | IPR003108 | |
| Domain | GAS2 | 1.70e-03 | 6 | 202 | 2 | SM00243 | |
| Domain | Spectrin | 1.88e-03 | 23 | 202 | 3 | PF00435 | |
| Domain | ANATO | 2.36e-03 | 7 | 202 | 2 | SM00104 | |
| Domain | Galactosyl_T | 2.36e-03 | 7 | 202 | 2 | IPR003859 | |
| Domain | Plectin | 2.36e-03 | 7 | 202 | 2 | PF00681 | |
| Domain | Glyco_transf_7N | 2.36e-03 | 7 | 202 | 2 | PF13733 | |
| Domain | ANAPHYLATOXIN_2 | 2.36e-03 | 7 | 202 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.36e-03 | 7 | 202 | 2 | PS01177 | |
| Domain | Plectin_repeat | 2.36e-03 | 7 | 202 | 2 | IPR001101 | |
| Domain | ANATO | 2.36e-03 | 7 | 202 | 2 | PF01821 | |
| Domain | Glyco_transf_7C | 2.36e-03 | 7 | 202 | 2 | PF02709 | |
| Domain | Galactosyl_T_C | 2.36e-03 | 7 | 202 | 2 | IPR027791 | |
| Domain | Galactosyl_T_N | 2.36e-03 | 7 | 202 | 2 | IPR027995 | |
| Domain | Anaphylatoxin/fibulin | 2.36e-03 | 7 | 202 | 2 | IPR000020 | |
| Domain | PLEC | 2.36e-03 | 7 | 202 | 2 | SM00250 | |
| Domain | Ank_2 | 2.41e-03 | 215 | 202 | 8 | PF12796 | |
| Domain | DAD_dom | 3.12e-03 | 8 | 202 | 2 | IPR014767 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 3.12e-03 | 8 | 202 | 2 | IPR019565 | |
| Domain | DAD | 3.12e-03 | 8 | 202 | 2 | PS51231 | |
| Domain | Thiol-ester_cl | 3.12e-03 | 8 | 202 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 3.12e-03 | 8 | 202 | 2 | IPR019742 | |
| Domain | Channel_four-helix_dom | 3.35e-03 | 57 | 202 | 4 | IPR027359 | |
| Domain | - | 3.35e-03 | 57 | 202 | 4 | 1.20.120.350 | |
| Domain | Ank | 3.45e-03 | 228 | 202 | 8 | PF00023 | |
| Domain | ARM-type_fold | SMG1 TRPC4AP PSMD1 FMNL2 LYST EFR3A DIAPH2 APOB HEATR5A XPO1 | 3.93e-03 | 339 | 202 | 10 | IPR016024 |
| Domain | Drf_GBD | 3.99e-03 | 9 | 202 | 2 | PF06371 | |
| Domain | Drf_FH3 | 3.99e-03 | 9 | 202 | 2 | PF06367 | |
| Domain | MYTH4 | 3.99e-03 | 9 | 202 | 2 | PS51016 | |
| Domain | MyTH4 | 3.99e-03 | 9 | 202 | 2 | SM00139 | |
| Domain | FH3_dom | 3.99e-03 | 9 | 202 | 2 | IPR010472 | |
| Domain | GTPase-bd | 3.99e-03 | 9 | 202 | 2 | IPR010473 | |
| Domain | MyTH4_dom | 3.99e-03 | 9 | 202 | 2 | IPR000857 | |
| Domain | MyTH4 | 3.99e-03 | 9 | 202 | 2 | PF00784 | |
| Domain | Drf_FH3 | 3.99e-03 | 9 | 202 | 2 | SM01139 | |
| Domain | Drf_GBD | 3.99e-03 | 9 | 202 | 2 | SM01140 | |
| Domain | AH/BAR-dom | 4.08e-03 | 30 | 202 | 3 | IPR027267 | |
| Domain | - | 4.08e-03 | 30 | 202 | 3 | 1.20.1270.60 | |
| Domain | A2M | 4.95e-03 | 10 | 202 | 2 | PF00207 | |
| Domain | A2M_N_2 | 4.95e-03 | 10 | 202 | 2 | IPR011625 | |
| Domain | A2M_comp | 4.95e-03 | 10 | 202 | 2 | IPR011626 | |
| Domain | GBP_C | 4.95e-03 | 10 | 202 | 2 | PF02841 | |
| Domain | A2M_recep | 4.95e-03 | 10 | 202 | 2 | PF07677 | |
| Domain | A2M_comp | 4.95e-03 | 10 | 202 | 2 | PF07678 | |
| Domain | A2M_N | 4.95e-03 | 10 | 202 | 2 | PF01835 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.92e-06 | 56 | 149 | 7 | MM17236 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | SETD1A ERCC2 ZNF273 ZNF267 ZNF195 PSMD1 BCL6 ZNF595 PSMD6 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 SESN2 ZNF730 CUL1 ZNF354A ZNF570 XPO1 PRDM7 ZNF354B RPRD1A ZNF732 ZNF253 ZNF92 ZNF667 CDK1 ZNF454 ZNF726 ZNF682 | 6.31e-06 | 1387 | 149 | 33 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | SETD1A ERCC2 ZNF267 ZNF195 PSMD1 ZNF595 PSMD6 ZNF836 ZNF610 ZNF347 ZNF624 SESN2 CUL1 ZNF354A ZNF695 ZNF354B ZNF667 CDK1 ZNF454 ZNF726 ZNF682 | 5.71e-05 | 768 | 149 | 21 | MM14851 |
| Pathway | WP_FOXA2_PATHWAY | 6.24e-05 | 21 | 149 | 4 | M42579 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 9.71e-05 | 136 | 149 | 8 | MM14848 | |
| Pubmed | ZNF273 ZNF267 ZNF195 ZNF595 ZNF257 ZNF624 ZNF480 ZNF766 ZNF354A ZNF354B ZNF253 ZNF92 ZNF726 | 7.30e-11 | 181 | 206 | 13 | 37372979 | |
| Pubmed | High-throughput microarray detection of olfactory receptor gene expression in the mouse. | 1.20e-09 | 4 | 206 | 4 | 15377787 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 1.61e-08 | 49 | 206 | 7 | 9630514 | |
| Pubmed | 1.70e-08 | 29 | 206 | 6 | 14563677 | ||
| Pubmed | PSMD1 ADD3 EFTUD2 DHX15 ZNF836 ZNF257 ZNF506 ZNF766 PLS3 CUL1 NAA15 XPO1 PABPC3 ZNF726 ZNF682 | 9.50e-08 | 451 | 206 | 15 | 36168627 | |
| Pubmed | CTTNBP2 TTC21A SPTBN1 FMNL2 ASAP1 ADD3 DHX15 PSMD6 DST C4A C4B PLS3 CNTN1 STOML2 KIAA1549 CNKSR2 XPO1 AP3M1 STRIP1 MLXIPL EIF2S1 PABPC3 PDE4DIP MACF1 SSH2 DCTN4 ATP1A2 | 1.17e-07 | 1431 | 206 | 27 | 37142655 | |
| Pubmed | SPTBN1 PSMD1 TTC3 FMNL2 ADD3 ZNF836 CYRIA DST ZNF624 GFPT2 WDR17 KLHL4 TTC28 UBA3 PIAS1 RPRD1A GUCY1B1 ZNF92 PDE4DIP NEMF CCAR1 MACF1 ATP1A2 B4GALT3 | 7.50e-07 | 1285 | 206 | 24 | 35914814 | |
| Pubmed | ACACA SPTBN1 PSMD1 PRPF6 ADD3 EFTUD2 DHX15 PSMD6 PLS3 CUL1 NAA15 XPO1 RPRD1A EIF2S1 CCAR1 CDK1 | 1.52e-06 | 638 | 206 | 16 | 33239621 | |
| Pubmed | CTTNBP2 FMNL2 TBC1D9 EFTUD2 ZNF836 ZNF610 ZNF347 TBC1D12 PLEKHH2 LRRN1 COBLL1 GBA2 MACF1 SSH2 | 1.67e-06 | 493 | 206 | 14 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACA SPTBN1 PRPF6 TTC6 DIAPH2 C4A C4B CUL1 ACAD9 XPO1 AP3M1 RGS12 CCAR1 HYDIN | 1.84e-06 | 497 | 206 | 14 | 36774506 |
| Pubmed | CTTNBP2 PDE1B SPTBN1 TTC3 EFTUD2 DST NFATC3 MAD1L1 DIAPH2 KCNT1 CNTN1 STOML2 CNKSR2 STRIP1 PABPC3 PDE4DIP CCAR1 MACF1 SSH2 | 5.28e-06 | 963 | 206 | 19 | 28671696 | |
| Pubmed | 5.38e-06 | 20 | 206 | 4 | 7479878 | ||
| Pubmed | 5.38e-06 | 20 | 206 | 4 | 2542606 | ||
| Pubmed | GBP7 SPTBN1 ZNF267 PSMD1 TTC3 ZNF595 ASAP1 TTBK2 EXOC3L1 GFPT2 CPLANE1 ACAD9 FRMPD1 MPEG1 APOB AP3M1 FEM1B PAXBP1 MACF1 ZNF726 | 7.93e-06 | 1084 | 206 | 20 | 11544199 | |
| Pubmed | SMG1 DST GLB1 TONSL DIAPH2 C4A C4B PGS1 NAA15 TTC28 ATL3 PIAS1 URGCP NEMF CCAR1 | 8.78e-06 | 650 | 206 | 15 | 38777146 | |
| Pubmed | SMG1 CTTNBP2 IMPA2 SPTBN1 PSMD1 BCL6 TTC3 ASAP1 DHX15 DST COL14A1 PDE4DIP MACF1 | 9.56e-06 | 497 | 206 | 13 | 23414517 | |
| Pubmed | The receptor guanylyl cyclase Npr2 is essential for sensory axon bifurcation within the spinal cord. | 9.69e-06 | 23 | 206 | 4 | 17954614 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACACA RGS22 SPTBN1 PSMD1 PRPF6 TTC3 EFTUD2 DHX15 PSMD6 CHST2 PLS3 STOML2 CUL1 ACAD9 APOB XPO1 PRDM7 PAXBP1 RPRD1A EIF2S1 NEMF CCAR1 CDK1 | 1.41e-05 | 1425 | 206 | 23 | 30948266 |
| Pubmed | 1.68e-05 | 9 | 206 | 3 | 10360839 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | SMG1 ACACA MYO9B FMNL2 LYST TBC1D9 CPLANE1 PGS1 ATL3 ASB14 AP3M1 PDE4DIP CDK1 | 2.86e-05 | 552 | 206 | 13 | 10737800 |
| Pubmed | MYO10 ASAP1 TTC28 VPS8 FRMPD1 CNKSR2 HEATR5A STRIP1 FEM1B PDE4DIP MACF1 | 3.48e-05 | 407 | 206 | 11 | 12693553 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 3.49e-05 | 2 | 206 | 2 | 16565498 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 15998580 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 3.49e-05 | 2 | 206 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 3.49e-05 | 2 | 206 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.49e-05 | 2 | 206 | 2 | 17645767 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.49e-05 | 2 | 206 | 2 | 27758680 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 22387014 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 11002341 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 3.49e-05 | 2 | 206 | 2 | 23749435 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 23918728 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 7777544 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.49e-05 | 2 | 206 | 2 | 3037333 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 11726230 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 3.49e-05 | 2 | 206 | 2 | 6950384 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.49e-05 | 2 | 206 | 2 | 8428773 | |
| Pubmed | Molecular mechanisms underlying the role of the centriolar CEP164-TTBK2 complex in ciliopathies. | 3.49e-05 | 2 | 206 | 2 | 34499853 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.49e-05 | 2 | 206 | 2 | 21345967 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 26627919 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 2572548 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 2302180 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 3.49e-05 | 2 | 206 | 2 | 18091514 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 29080553 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.49e-05 | 2 | 206 | 2 | 25339671 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 17728371 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 6149580 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 6149581 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 12115608 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 3542363 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 2387317 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 16908004 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 7365238 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 7391573 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 3.49e-05 | 2 | 206 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.49e-05 | 2 | 206 | 2 | 17971229 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 6881182 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 3.49e-05 | 2 | 206 | 2 | 17921792 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 3.49e-05 | 2 | 206 | 2 | 6978711 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 25963737 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 35898513 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 28873507 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 3.49e-05 | 2 | 206 | 2 | 6832377 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 3794341 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 22785613 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 3.49e-05 | 2 | 206 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 3.49e-05 | 2 | 206 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 3.49e-05 | 2 | 206 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 3.49e-05 | 2 | 206 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 3.49e-05 | 2 | 206 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 3.49e-05 | 2 | 206 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 3.49e-05 | 2 | 206 | 2 | 15787745 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 30026462 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 3.49e-05 | 2 | 206 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 3.49e-05 | 2 | 206 | 2 | 20506482 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 12480675 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 3.49e-05 | 2 | 206 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 3.49e-05 | 2 | 206 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 3.49e-05 | 2 | 206 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 3.49e-05 | 2 | 206 | 2 | 3624865 | |
| Pubmed | Transcriptional regulation of human organic anion transporter 1 by B-cell CLL/lymphoma 6. | 3.49e-05 | 2 | 206 | 2 | 25234312 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 21857912 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 3.49e-05 | 2 | 206 | 2 | 4514997 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 3.49e-05 | 2 | 206 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 3.49e-05 | 2 | 206 | 2 | 3167981 | |
| Pubmed | KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2. | 3.49e-05 | 2 | 206 | 2 | 37140813 | |
| Cytoband | 1q44 | 1.41e-04 | 110 | 205 | 5 | 1q44 | |
| Cytoband | 4p15.3 | 1.97e-04 | 5 | 205 | 2 | 4p15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 2.29e-04 | 122 | 205 | 5 | chr19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.87e-04 | 128 | 205 | 5 | chr1q44 | |
| Cytoband | 19q13.41 | 4.25e-04 | 78 | 205 | 4 | 19q13.41 | |
| Cytoband | 19p12 | 7.31e-04 | 90 | 205 | 4 | 19p12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF273 ZNF267 ZNF195 BCL6 ZNF595 ZNF836 ZNF610 ZNF547 ZNF257 ZNF347 ZNF506 ZNF624 ZNF480 ZNF766 ZNF730 ZNF354A ZNF695 ZNF570 PRDM7 ZNF354B ZSCAN5B ZNF732 ZNF253 ZNF92 ZNF667 ZNF525 ZNF454 ZNF726 ZNF682 | 2.63e-13 | 718 | 142 | 29 | 28 |
| GeneFamily | Guanylate cyclase receptors | 1.62e-05 | 7 | 142 | 3 | 343 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.44e-05 | 115 | 142 | 7 | 769 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 9.91e-05 | 12 | 142 | 3 | 660 | |
| GeneFamily | Ankyrin repeat domain containing | 6.60e-04 | 242 | 142 | 8 | 403 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.66e-03 | 8 | 142 | 2 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.13e-03 | 9 | 142 | 2 | 1234 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ABCC3 CTTNBP2 MYO10 SPTBN1 TMTC2 ADD3 IGSF10 DST COL14A1 CHST2 PLEKHH2 CNTN1 FAT3 CNKSR2 MACF1 | 2.52e-14 | 197 | 205 | 15 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CTTNBP2 SPTBN1 TMTC2 ADD3 DST COL14A1 CHST2 PLEKHH2 CNTN1 FAT3 CNKSR2 MACF1 | 1.41e-10 | 197 | 205 | 12 | 11a4c417f035e554431a8f03be13b5eefa3530c0 |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | ABCC3 SPTBN1 IGSF10 DST COL14A1 CHST2 PLEKHH2 CNTN1 FAT3 CNKSR2 MACF1 | 2.33e-09 | 199 | 205 | 11 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ABCC3 CTTNBP2 BCL6 CFAP54 PKHD1 PLEKHH2 FAT3 COBLL1 SKAP1 HYDIN | 2.12e-08 | 191 | 205 | 10 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CTTNBP2 MYO10 SPTBN1 IGSF10 DST COL14A1 CHST2 PLEKHH2 FAT3 MACF1 | 2.84e-08 | 197 | 205 | 10 | 31a1852911bda38543916585fda34255fd62a134 |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.23e-08 | 161 | 205 | 9 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.45e-07 | 189 | 205 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.56e-07 | 190 | 205 | 9 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-07 | 191 | 205 | 9 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 176 | 205 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 1.64e-06 | 176 | 205 | 8 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 184 | 205 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 184 | 205 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 184 | 205 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-06 | 190 | 205 | 8 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 190 | 205 | 8 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.89e-06 | 190 | 205 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 191 | 205 | 8 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 191 | 205 | 8 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 194 | 205 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.38e-06 | 194 | 205 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.38e-06 | 194 | 205 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.51e-06 | 195 | 205 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.51e-06 | 195 | 205 | 8 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 196 | 205 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 196 | 205 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.93e-06 | 198 | 205 | 8 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 4.07e-06 | 199 | 205 | 8 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 4.23e-06 | 200 | 205 | 8 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.23e-06 | 200 | 205 | 8 | 081ca331b56f85167acfc73af9d2e91f398f8c4d | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.23e-06 | 200 | 205 | 8 | 940892bea41fde567f138a896d151acccef03a6a | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.23e-06 | 200 | 205 | 8 | 0ed49c2177b58269ff7653db6be7d68633a5d34a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK---L2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.23e-06 | 200 | 205 | 8 | 6ebdae4438bc64c6620416f64a7e22fbca2664bf | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.23e-06 | 200 | 205 | 8 | 66e2f3e2e9063f17b47621120eb6009405f69e7e | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.07e-06 | 156 | 205 | 7 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 158 | 205 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 158 | 205 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-05 | 162 | 205 | 7 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 164 | 205 | 7 | 875d922eec7e3df0998ddf0c8c4dee2dcd5b23ca | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 166 | 205 | 7 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 168 | 205 | 7 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-05 | 170 | 205 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 171 | 205 | 7 | 5b74df72e36ad04dfb25c72f1ca8efe043f6cda6 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 173 | 205 | 7 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 173 | 205 | 7 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 176 | 205 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 177 | 205 | 7 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 178 | 205 | 7 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 2.04e-05 | 180 | 205 | 7 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-05 | 182 | 205 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 123 | 205 | 6 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 2.43e-05 | 185 | 205 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 186 | 205 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.79e-05 | 189 | 205 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 191 | 205 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.99e-05 | 191 | 205 | 7 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.09e-05 | 192 | 205 | 7 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 3.09e-05 | 192 | 205 | 7 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.09e-05 | 192 | 205 | 7 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.19e-05 | 193 | 205 | 7 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 193 | 205 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 193 | 205 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.19e-05 | 193 | 205 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 195 | 205 | 7 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 195 | 205 | 7 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 195 | 205 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.41e-05 | 195 | 205 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 195 | 205 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.52e-05 | 196 | 205 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.52e-05 | 196 | 205 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 196 | 205 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 196 | 205 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 205 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 197 | 205 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 197 | 205 | 7 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 197 | 205 | 7 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 197 | 205 | 7 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 197 | 205 | 7 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 3.88e-05 | 199 | 205 | 7 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | Transverse-Dendritic_cell-cDC1|Transverse / Region, Cell class and subclass | 3.88e-05 | 199 | 205 | 7 | b68419939d206417158a703f60a374bf8ec5d5a1 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(51)_cDC1|Transverse / shred on region, Cell_type, and subtype | 3.88e-05 | 199 | 205 | 7 | 52dd1c4cd372f8ee515307a9200e357bb2145888 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 199 | 205 | 7 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.00e-05 | 200 | 205 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-05 | 157 | 205 | 6 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.51e-05 | 159 | 205 | 6 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 160 | 205 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.84e-05 | 160 | 205 | 6 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.84e-05 | 160 | 205 | 6 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 160 | 205 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 162 | 205 | 6 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 162 | 205 | 6 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 164 | 205 | 6 | b175258fb0885afd84d4a414c0ae441f880e8469 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 164 | 205 | 6 | 8bcfc93220d7c99dddb32b7fa7fb9aec2a1c63fa | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 166 | 205 | 6 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 169 | 205 | 6 | 3f8aa6d2f9aa060ae1a0ea3eb47e794099fc2c2c | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 169 | 205 | 6 | 26de495c7562e0740689d0f78e803698e3e793db | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 169 | 205 | 6 | e36b8cd0230bbb761df7606129ebfd77111af10b | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 170 | 205 | 6 | 670027daec5a10dfa12246f1497b58db21d32a22 | |
| Computational | Genes in the cancer module 65. | 2.16e-06 | 10 | 111 | 4 | MODULE_65 | |
| Computational | Genes in the cancer module 445. | 1.35e-05 | 15 | 111 | 4 | MODULE_445 | |
| Drug | AC1NBU2S | TONSL CACNA1I CACNA1G CNGA2 ICOSLG NPR2 GUCY1B1 GUCY2F GUCY2D | 9.88e-07 | 117 | 201 | 9 | CID004473765 |
| Disease | Mediastinal (Thymic) Large B-Cell Lymphoma | 4.17e-05 | 2 | 191 | 2 | C1292754 | |
| Disease | coffee consumption measurement | 1.92e-04 | 182 | 191 | 7 | EFO_0006781 | |
| Disease | superior temporal gyrus volume measurement | 2.40e-04 | 19 | 191 | 3 | EFO_0010331 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.10e-04 | 50 | 191 | 4 | EFO_0022247 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 4.80e-04 | 56 | 191 | 4 | EFO_0022251 | |
| Disease | low density lipoprotein particle size measurement | 5.49e-04 | 58 | 191 | 4 | EFO_0008593 | |
| Disease | triglycerides to total lipids in large HDL percentage | 6.25e-04 | 60 | 191 | 4 | EFO_0022330 | |
| Disease | cholesterol to total lipids in IDL percentage | 6.25e-04 | 60 | 191 | 4 | EFO_0022233 | |
| Disease | Colorectal Carcinoma | ABCC3 ERCC2 ACACA PKHD1 ZNF624 ZNF480 SESN2 CNTN1 FPGS CNKSR2 APOB CCAR1 GABRA6 | 6.98e-04 | 702 | 191 | 13 | C0009402 |
| Disease | Ciliopathies | 7.62e-04 | 110 | 191 | 5 | C4277690 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 8.57e-04 | 7 | 191 | 2 | C2745997 | |
| Disease | hearing loss | 9.48e-04 | 67 | 191 | 4 | EFO_0004238 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 9.48e-04 | 67 | 191 | 4 | EFO_0022245 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.17e-03 | 121 | 191 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.17e-03 | 121 | 191 | 5 | EFO_0004612, EFO_0005271 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.37e-03 | 74 | 191 | 4 | EFO_0022280 | |
| Disease | celiac disease | 1.40e-03 | 126 | 191 | 5 | EFO_0001060 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.45e-03 | 127 | 191 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | Spastic Paraplegia | 1.46e-03 | 9 | 191 | 2 | C0037772 | |
| Disease | neuroimaging measurement | CTTNBP2 SPTBN1 PSMD1 EFTUD2 CYRIA PKHD1 FAT3 CNKSR2 XPO1 MLXIPL PABPC3 MACF1 UQCC1 CDK1 SSH2 TMC5 | 1.67e-03 | 1069 | 191 | 16 | EFO_0004346 |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.76e-03 | 37 | 191 | 3 | EFO_0022252 | |
| Disease | non-melanoma skin carcinoma | 1.77e-03 | 265 | 191 | 7 | EFO_0009260 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.81e-03 | 10 | 191 | 2 | OBA_2045163 | |
| Disease | Graves' disease (is_implicated_in) | 2.06e-03 | 39 | 191 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | ovary epithelial cancer (is_implicated_in) | 2.21e-03 | 11 | 191 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 2.21e-03 | 11 | 191 | 2 | OBA_2045170 | |
| Disease | Occupational Diseases | 2.21e-03 | 11 | 191 | 2 | C0028797 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.51e-03 | 144 | 191 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 2.55e-03 | 42 | 191 | 3 | EFO_0022255 | |
| Disease | triglycerides in large LDL measurement | 2.72e-03 | 43 | 191 | 3 | EFO_0022319 | |
| Disease | tuberculosis | 2.91e-03 | 216 | 191 | 6 | MONDO_0018076 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.99e-03 | 150 | 191 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | alcohol consumption measurement | CYP1A1 SETD1A CTTNBP2 ACACA SPTBN1 TMEM216 FMNL2 B4GALT1 DHX15 CYRIA MAD1L1 PKHD1 CACNA1I COBLL1 RGS12 MLXIPL GABRA2 | 3.05e-03 | 1242 | 191 | 17 | EFO_0007878 |
| Disease | velocity of sound measurement | 3.10e-03 | 13 | 191 | 2 | EFO_0005654 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 3.10e-03 | 13 | 191 | 2 | EFO_0800474 | |
| Disease | gallbladder cancer (is_implicated_in) | 3.10e-03 | 13 | 191 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.33e-03 | 222 | 191 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | Celiac Disease | 3.51e-03 | 47 | 191 | 3 | C0007570 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.56e-03 | 225 | 191 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | white matter microstructure measurement | 4.05e-03 | 390 | 191 | 8 | EFO_0005674 | |
| Disease | rectum cancer, overall survival | 4.14e-03 | 15 | 191 | 2 | EFO_0000638, EFO_1000657 | |
| Disease | triacylglycerol 52:3 measurement | 4.14e-03 | 15 | 191 | 2 | EFO_0010415 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 4.18e-03 | 50 | 191 | 3 | EFO_0022303 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 4.26e-03 | 101 | 191 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | triglycerides to total lipids in large LDL percentage | 4.43e-03 | 51 | 191 | 3 | EFO_0022331 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 4.43e-03 | 51 | 191 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 4.43e-03 | 51 | 191 | 3 | EFO_0022240 | |
| Disease | telomere length | 4.44e-03 | 313 | 191 | 7 | EFO_0004505 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 4.57e-03 | 103 | 191 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | sodium measurement | 4.57e-03 | 103 | 191 | 4 | EFO_0009282 | |
| Disease | coffee consumption, cups of coffee per day measurement | 4.71e-03 | 16 | 191 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | sleep duration, triglyceride measurement | 4.73e-03 | 104 | 191 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.77e-03 | 239 | 191 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 4.93e-03 | 53 | 191 | 3 | EFO_0022340 | |
| Disease | triglycerides in HDL measurement | 4.93e-03 | 53 | 191 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 4.93e-03 | 53 | 191 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 4.93e-03 | 53 | 191 | 3 | EFO_0022258 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.17e-03 | 243 | 191 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | total lipids in medium VLDL | 5.20e-03 | 54 | 191 | 3 | EFO_0022153 | |
| Disease | Hepatomegaly | 5.20e-03 | 54 | 191 | 3 | C0019209 | |
| Disease | triglycerides in medium HDL measurement | 5.20e-03 | 54 | 191 | 3 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 5.20e-03 | 54 | 191 | 3 | EFO_0022244 | |
| Disease | copine-1 measurement | 5.32e-03 | 17 | 191 | 2 | EFO_0008102 | |
| Disease | triglycerides in medium VLDL measurement | 5.47e-03 | 55 | 191 | 3 | EFO_0022155 | |
| Disease | cholesterol to total lipids in large HDL percentage | 5.47e-03 | 55 | 191 | 3 | EFO_0022234 | |
| Disease | triglycerides in large VLDL measurement | 5.75e-03 | 56 | 191 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 5.75e-03 | 56 | 191 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 5.75e-03 | 56 | 191 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 5.75e-03 | 56 | 191 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 5.75e-03 | 56 | 191 | 3 | EFO_0022316 | |
| Disease | cholesterol to total lipids in large LDL percentage | 5.75e-03 | 56 | 191 | 3 | EFO_0022235 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 5.75e-03 | 56 | 191 | 3 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 6.04e-03 | 57 | 191 | 3 | EFO_0022284 | |
| Disease | triglycerides in IDL measurement | 6.34e-03 | 58 | 191 | 3 | EFO_0022149 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGILRLYEDILLQMD | 701 | O60347 | |
| RAVVLQYLSALMQGR | 591 | Q86VI1 | |
| MLSDGLNSLTYQVLD | 366 | P15291 | |
| QDGMNSLTYQLLARE | 316 | O60512 | |
| QNSGLIRDSYLEMAL | 2646 | Q96N23 | |
| ARLLLAALVQDYVQM | 46 | P10092 | |
| LNMGITDLQGLRLYV | 326 | P0C0L5 | |
| YLAMNRLGVLRDDND | 431 | O15254 | |
| SGLVQYQMAQLLRDR | 356 | Q96QU6 | |
| QLDLAGLDLTNYLMV | 176 | Q9BYD9 | |
| IMSLSVLLDYRLEDN | 746 | Q8IX12 | |
| TGLLALQQIADYIMA | 86 | Q9UEY8 | |
| ITLLRDLMLVAQQAY | 496 | Q9NXL2 | |
| ILLIFEGTNEILRMY | 421 | Q9H845 | |
| ILINLYGMTAVLSRA | 536 | Q9H845 | |
| VIQYALNDEVMLRLL | 421 | Q8WXK1 | |
| LNDEVMLRLLLNNGY | 426 | Q8WXK1 | |
| GFLMLLYVILNENEN | 61 | Q4W4Y0 | |
| YLQNEGERLLLEAMD | 1441 | Q13085 | |
| NYLARETESVLLMIG | 136 | Q5VUY2 | |
| GQIRLRALYALQEEM | 241 | Q53GS7 | |
| RALYALQEEMLQLSQ | 246 | Q53GS7 | |
| SILDNLLLRMEQYAN | 796 | P20594 | |
| LAAQGEMLYLATRIE | 156 | Q9H9E1 | |
| MAALLINYGADVNLR | 166 | A6NK59 | |
| QIALRMGNYELISLL | 391 | A6NK59 | |
| LAYLMLVNDDSIRIV | 686 | Q96K78 | |
| QLAISGLKVNRLDMY | 381 | Q9Y2T2 | |
| IGVYELQRLLNRMAI | 586 | Q9UMQ6 | |
| NRLLELVLLVGNYMN | 831 | O60879 | |
| LMRALELLNYLAALN | 536 | O43143 | |
| NDLGLRELYAMDVNR | 206 | Q53SF7 | |
| SGYVLIAMEALDQLL | 71 | Q14156 | |
| LALSRMSQQYGDVLQ | 61 | P04798 | |
| QTRMATYLAELLVLN | 186 | Q2M385 | |
| MLLATLLIQYERLQG | 116 | O15438 | |
| NKMDLQRAAIILGYR | 1261 | Q9HCM3 | |
| QLAISGLKVNRLDMY | 381 | P53677 | |
| DVATMLNILALVYRD | 251 | Q9NSK0 | |
| LVGMAQLRELYLTSN | 471 | Q7Z5L7 | |
| MGNLLKVLTREIENY | 1 | Q9H0Q0 | |
| MLEAQLERRALQGDY | 521 | Q9Y6D9 | |
| GVDLTRLLNDMRAQY | 291 | Q99456 | |
| ELNASLLGMRVNNVY | 16 | O60524 | |
| LRMLEQYSSNLEDLI | 821 | Q02846 | |
| INSYMDANTGQRLLL | 1996 | Q03001 | |
| LLEYNNIEGMILLSE | 36 | P05198 | |
| LYLQMNNLRAEGTAV | 96 | A0A0C4DH36 | |
| LNGLSSSVEYNIMEL | 251 | Q8WVP7 | |
| SNILMVGNYASDLEL | 396 | Q53G44 | |
| IYLQGSALKDQDLMR | 411 | Q5JUK3 | |
| ATLDLLVENMGRVNY | 471 | P16278 | |
| LYLAMLERFQDGDNI | 276 | Q9UK73 | |
| LRIQDDGTLLYTMRL | 146 | P47869 | |
| AEYQLMTGLQILQER | 126 | Q9H2K0 | |
| QLRQARAMGDYLIVG | 41 | Q99447 | |
| LMRRYTLNVLEDLGD | 501 | P13797 | |
| GNSVMVLLIYLDTQL | 41 | Q96R28 | |
| GNSVMVLLIYLDTQL | 41 | Q8NG83 | |
| GNSVMVLLIYLDTQL | 41 | A3KFT3 | |
| GNSIMVLLIYLDTQL | 41 | Q8NG81 | |
| RSLLRYMVKQLENGE | 36 | Q01064 | |
| LTQAYMDLVLGTRAE | 391 | Q32NB8 | |
| MDLVLGTRAEYQILL | 396 | Q32NB8 | |
| MAEYGTLLQDLTNNI | 1 | Q15121 | |
| SLLQIQMRDLEGYRE | 121 | Q6N069 | |
| AVVLNQLRYSGMLET | 651 | Q9HD67 | |
| VIRNYGNLLLEMSAV | 516 | P18074 | |
| RLGMLVETYLDAINS | 291 | Q8N8V2 | |
| NGTILYTMRLTINAD | 141 | Q16445 | |
| SVMNLDDLTRRGLYL | 326 | Q02153 | |
| MQSLNDRLAGYLEKV | 101 | Q92764 | |
| QELSIDGLLNRYILM | 796 | Q9Y5B6 | |
| ENMILLTIQYLVRLG | 451 | Q9C091 | |
| MLIAQALQTINYGRD | 271 | O14732 | |
| GLTLQTYVQLTMLDR | 106 | O00142 | |
| ELGVYLMNLSIADLL | 51 | P46093 | |
| DVQNRQGELGMLLSY | 356 | Q9C0H6 | |
| SLLQIQMRDLEGYRE | 121 | Q9BXJ9 | |
| DGLSLLEYNSMRLIV | 1376 | Q8IVE3 | |
| EETYNQLLDKGRLML | 6386 | Q9UPN3 | |
| ITGMLLEIDNSELLY | 576 | Q9H361 | |
| LNMRGLYDVVSVLRI | 191 | O75144 | |
| MDIQQELQRYLSLVG | 2526 | P04114 | |
| LVNERLISMAYGQIG | 841 | P50993 | |
| RINLGYNSLVRLMET | 61 | Q6WRI0 | |
| VSLYGAAIDMNIRLD | 286 | Q4G0P3 | |
| QGRYEIMLSLQNILN | 151 | Q86XA9 | |
| LALELYTQRSLLVMG | 531 | O94808 | |
| IAGMLEYSLDLQNVS | 161 | O43497 | |
| RIMTNIYLLNLAISD | 66 | P51677 | |
| RRISQAYGLMNELLS | 2961 | Q9H799 | |
| AYGLMNELLSESVQL | 2966 | Q9H799 | |
| LSLQYDMALATLRED | 556 | Q9HCG7 | |
| LSMLLNEEGLDINYS | 726 | Q8WZ74 | |
| DMLDYLLSLGQISRR | 51 | Q8WW52 | |
| INTILITNLLSGMDY | 881 | Q05707 | |
| NEDLGRMYNLVSRIQ | 316 | Q13616 | |
| MLQDRESYIALLVGA | 406 | Q5SYB0 | |
| GMVEYSLDLQNINLS | 161 | Q9P0X4 | |
| VTDYGFNDILEMLRL | 686 | P51841 | |
| QEKVLNMLRALYGNL | 416 | Q49AR2 | |
| YQRNFMLDSNGELLI | 556 | Q12860 | |
| YVNSQSRMGITLIDL | 61 | Q8TDW7 | |
| ELLLTIQMGIDNLYV | 401 | Q5T5S1 | |
| LLALIQVYAEGVELM | 576 | Q9ULH1 | |
| LQLFTEYGRLAMDEI | 186 | Q6DD88 | |
| MAQLLQYRAVSLLEE | 616 | Q674R7 | |
| ELLAEAGNYSALQRM | 296 | Q9NY43 | |
| YTSRLNLREGNIMAV | 91 | P41182 | |
| ILEIILALGNYMNSS | 821 | Q96PY5 | |
| RVIEDLIVMLGYLQN | 2521 | Q99698 | |
| LEAMELYLARSGLQV | 76 | Q05932 | |
| ETYALMSDNLLRVLG | 241 | Q96G42 | |
| MASLLQSDRVLYLVQ | 1 | Q9UJW0 | |
| MYRGILDALLQTART | 246 | Q3KQZ1 | |
| RALRQLAQSLYMVGV | 131 | Q4U2R8 | |
| LNMGITDLQGLRLYV | 326 | P0C0L4 | |
| RIGLFYMDNDLITRN | 146 | Q15008 | |
| NLRSLVLAGMYLTDI | 216 | Q6UXK5 | |
| SDLMYDNVVRQLLAA | 371 | Q96RD6 | |
| NLLLLEARMQAALLY | 456 | P58004 | |
| EARMQAALLYALRAI | 461 | P58004 | |
| LQRLESYIQMLNGVS | 111 | Q96GJ1 | |
| RDVLQSYFDLLGELM | 576 | Q8TEL6 | |
| MENLLQSLYVENRAG | 661 | Q8NE09 | |
| LEYRAGLKNIANTLM | 786 | O94906 | |
| LEQMLYRELRVFSGN | 156 | Q9UL41 | |
| GLMNLYILNMAIADL | 86 | O15218 | |
| YILNMAIADLGIVLS | 91 | O15218 | |
| SLQAYLRNAAMGLEE | 2906 | Q96Q15 | |
| MNYNALITVGLRATR | 56 | Q9NQW5 | |
| NYVRQGALIASALIM | 681 | Q99460 | |
| ADSTDLRVLLNIMYL | 211 | Q5VSL9 | |
| AMAYLIRGNELELAV | 976 | Q8IZU2 | |
| ILGMLDTFNYEQTLL | 1211 | Q8N3P4 | |
| LVIGVARLMNYTDLD | 1126 | P08F94 | |
| LVMNFADVLLERGQY | 606 | Q96JS3 | |
| VMSLRVSELQVLLGY | 11 | O75925 | |
| QYMGQRGRIQESLDL | 461 | P0DKV0 | |
| LNLGGEMLYILDQRL | 11 | Q8WVF1 | |
| TAEYILMLQQERAGL | 696 | Q9NP71 | |
| IYDFVNSLELMDRLG | 656 | O15047 | |
| QYMFLRQRLQALDTG | 1136 | Q01082 | |
| LQDVLMQDSRLYLIF | 66 | P06493 | |
| RLGYMSASEQLRLLQ | 1381 | Q9UPV0 | |
| GYALLLVLTMLNLLD | 61 | Q9Y4C5 | |
| LGQLETNMETLYTRF | 601 | Q16280 | |
| LNRINMLTAGYAERE | 661 | Q8WXI2 | |
| VMLENYRNLVSLGIS | 36 | Q8N782 | |
| DVMLENYRNLVFLGI | 51 | Q8N9Z0 | |
| DVMLENYRNLVSLGL | 41 | Q5HYK9 | |
| NGMLISLLNYEDGVL | 176 | Q8TBC4 | |
| SRLQEMLSLLGLETY | 71 | Q8TCY9 | |
| YDRLLLQSSLDLMAD | 291 | Q9UBS8 | |
| QLLNSYLGTTLRTME | 286 | Q6YI46 | |
| DVMLENYRNLVSLGL | 81 | Q9P2J8 | |
| FVIQLGRIYLDMLNV | 706 | O14980 | |
| MLDNYRNLVFLGIAV | 66 | Q14593 | |
| DVMLENYRNLVSLGF | 31 | Q8IYB9 | |
| DVMLENYRNLVFLGI | 31 | Q03936 | |
| LTMLDLSYNNLNVVG | 276 | O15455 | |
| DVMLENYRNLISLGE | 31 | Q8IW36 | |
| QMALTDYGIVLLLDA | 156 | Q86TZ1 | |
| LDASILNVAMIVGYL | 221 | O14924 | |
| NLRIMIQYLLSGFEL | 496 | Q5VZE5 | |
| MRQLEEYQGILLASK | 436 | Q76I76 | |
| MLLADYNGRLAAEID | 221 | Q96P16 | |
| DNVAMGYLALLQVAT | 1351 | Q9Y5Y9 | |
| TLAQGELNEMRTRLY | 151 | Q96HA7 | |
| ELNEMRTRLYLNLGL | 156 | Q96HA7 | |
| MADMLYNLGLLLQEN | 526 | Q8N394 | |
| DVMLENYRNLVSLGL | 31 | Q14586 | |
| VNLLGKEYLMLNSDV | 131 | A6NJL1 | |
| YVVMQLQGRNLADLR | 91 | Q6IQ55 | |
| NEMGIAALRRVLTAY | 576 | Q6ZT07 | |
| RLVGILYLNESGTML | 126 | Q96B77 | |
| ENIALVTSMYDGLLQ | 261 | Q9Y5S1 | |
| KVMLENYRNLVSLGL | 31 | O95780 | |
| RRGLLTIYMANLATE | 121 | Q86UB9 | |
| RSLIQDGYMALLEQR | 491 | P53804 | |
| INLQMFIGTADDRYL | 476 | Q12968 | |
| MELVLSELEAAQRYL | 186 | Q96LQ0 | |
| NVTLQIDGVLYLRIM | 96 | Q9UJZ1 | |
| IQYLDSMNGEDLLLT | 256 | Q9NVA1 | |
| MLELAQLYLLQGHLD | 926 | Q8NDW8 | |
| NVMLDNYRNLVFLGI | 31 | Q6ZMV8 | |
| VMLENYRNLASLGIS | 36 | Q96SE7 | |
| MLENYRNLVSLGISL | 56 | Q8WV37 | |
| NVMLENYRNLAFLGI | 31 | A6NNF4 | |
| DVMLENYRNLVFLGI | 31 | O75346 | |
| AVMYLQEGLRLAEQL | 1096 | Q96AY4 | |
| YRDVMLENLALLSSL | 36 | Q8IVP9 | |
| NVMLENYRILVSLGL | 41 | Q96NI8 | |
| DVMLENYSNLVSLGL | 41 | Q8N9F8 | |
| DVMLENYRNLVFLGI | 31 | Q6ZN08 | |
| IRGQDAEMLSYLTNL | 266 | Q8N831 | |
| MARGLNVSALISINY | 631 | Q5TAH2 | |
| QSLLTGYIQTDLRGM | 166 | Q96DR4 | |
| ETLIGQDIYRLLLMD | 726 | Q6UXY8 | |
| TLYLDQMATLIGQTR | 376 | Q9WJR5 | |
| DVMLENYRNLVSLGL | 41 | O60765 | |
| DVMLENYRNLVSLGI | 36 | Q5HY98 | |
| DVMLENYRNLVSLGL | 41 | Q96LW1 | |
| DVMLENYRNLISLGV | 31 | B4DXR9 | |
| LKRLGVLLDYDNNML | 651 | Q9UJV3 | |
| NGLISMYSTDENLIL | 286 | Q15029 | |
| TYVLRLEAIMNGILL | 111 | Q9P0N5 | |
| QRGDLIRILSKEYNM | 316 | Q86WV1 | |
| DVMLENYRNLIFLGI | 31 | Q5JVG8 | |
| DVMLENYRNLFSVGL | 31 | O14628 | |
| VMLENYRNLVFLGIL | 36 | Q6ZNA1 | |
| DVMLENYRNLVFLGI | 31 | Q9Y2Q1 | |
| ELARLLRDYQAMLGV | 441 | Q7Z794 | |
| DELVLQQLRYTGMLE | 866 | Q13459 | |
| MERNSELQALRQYLG | 671 | Q5VU43 |